Pages that link to "Q39959003"
Jump to navigation
Jump to search
The following pages link to Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. (Q39959003):
Displaying 50 items.
- Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation (Q24293492) (← links)
- PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin (Q24338826) (← links)
- Small molecule inhibitors of zinc-dependent histone deacetylases (Q26824515) (← links)
- Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes (Q26830233) (← links)
- HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? (Q27015801) (← links)
- Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays (Q28550025) (← links)
- Insecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprina (Q28818731) (← links)
- Virtual screening and experimental validation of novel histone deacetylase inhibitors (Q28829470) (← links)
- A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors (Q28830529) (← links)
- Carbamate prodrug concept for hydroxamate HDAC inhibitors (Q30318440) (← links)
- Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity (Q30366109) (← links)
- Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides (Q33496543) (← links)
- Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells (Q33607294) (← links)
- Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules. (Q33798591) (← links)
- Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH. (Q33931893) (← links)
- A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold (Q33940304) (← links)
- Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A (Q34044049) (← links)
- Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents (Q34055631) (← links)
- Expedient synthesis of a 72-membered isoxazolino-β-ketoamide library by a 2·3-component reaction. (Q34105534) (← links)
- A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs. (Q34146683) (← links)
- New insights into the treatment of multiple myeloma with histone deacetylase inhibitors (Q34224278) (← links)
- Characterization of phytochemicals and evaluation of anti-cancer potential of Blumea eriantha DC. (Q34288336) (← links)
- CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. (Q34452444) (← links)
- Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells (Q35096555) (← links)
- Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species (Q35214605) (← links)
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma (Q35915726) (← links)
- Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition (Q36020172) (← links)
- Discovery of histone deacetylase 8 selective inhibitors (Q36111962) (← links)
- Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4) (Q36187278) (← links)
- Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes (Q36303155) (← links)
- Discovery of a Novel HDAC2 Inhibitor by a Scaffold-Merging Hybrid Query (Q36368454) (← links)
- 3-(4-Meth-oxy-phen-yl)-5-methylisoxazole-4-carb-oxy-lic acid (Q36657153) (← links)
- HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade (Q36912547) (← links)
- HDAC6 and ovarian cancer (Q36913610) (← links)
- Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma (Q37078946) (← links)
- Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors (Q37397325) (← links)
- Dido3-dependent HDAC6 targeting controls cilium size. (Q37680014) (← links)
- Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. (Q38031633) (← links)
- Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia (Q38136307) (← links)
- Histone deacetylase 6 in health and disease (Q38357741) (← links)
- DIDO as a Switchboard that Regulates Self-Renewal and Differentiation in Embryonic Stem Cells (Q38711155) (← links)
- HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells (Q38777310) (← links)
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. (Q38877252) (← links)
- HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages (Q38980182) (← links)
- Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species. (Q39096632) (← links)
- tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells (Q39176128) (← links)
- Inhibitors selective for HDAC6 in enzymes and cells (Q39644032) (← links)
- Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity (Q39856021) (← links)
- Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (Q41838047) (← links)
- 1-(3-p-Tolyl-isoxazol-5-yl)cyclo-hexa-nol (Q41932477) (← links)